SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-22-210023
Filing Date
2022-08-02
Accepted
2022-08-02 16:14:36
Documents
5
Effectiveness Date
2022-08-02

Document Format Files

Seq Description Document Type Size
1 S-8 d325482ds8.htm S-8 34023
2 EX-5.1 d325482dex51.htm EX-5.1 4786
3 EX-23.2 d325482dex232.htm EX-23.2 1244
4 EX-FILING FEES d325482dexfilingfees.htm EX-FILING FEES 13951
5 GRAPHIC g325482g0802091251365.jpg GRAPHIC 2682
  Complete submission text file 0001193125-22-210023.txt   59157
Mailing Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142 617-274-4000
Sarepta Therapeutics, Inc. (Filer) CIK: 0000873303 (see all company filings)

IRS No.: 930797222 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-266461 | Film No.: 221128881
SIC: 2834 Pharmaceutical Preparations